372 related articles for article (PubMed ID: 32265308)
1. Vascular permeability in the fibrotic lung.
Probst CK; Montesi SB; Medoff BD; Shea BS; Knipe RS
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32265308
[TBL] [Abstract][Full Text] [Related]
2. Endothelial-Specific Loss of Sphingosine-1-Phosphate Receptor 1 Increases Vascular Permeability and Exacerbates Bleomycin-induced Pulmonary Fibrosis.
Knipe RS; Spinney JJ; Abe EA; Probst CK; Franklin A; Logue A; Giacona F; Drummond M; Griffith J; Brazee PL; Hariri LP; Montesi SB; Black KE; Hla T; Kuo A; Cartier A; Engelbrecht E; Christoffersen C; Shea BS; Tager AM; Medoff BD
Am J Respir Cell Mol Biol; 2022 Jan; 66(1):38-52. PubMed ID: 34343038
[TBL] [Abstract][Full Text] [Related]
3. Vascular Contribution to Lung Repair and Fibrosis.
Caporarello N; Ligresti G
Am J Respir Cell Mol Biol; 2023 Aug; 69(2):135-146. PubMed ID: 37126595
[TBL] [Abstract][Full Text] [Related]
4. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
5. Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
Chakraborty S; Chopra P; Ambi SV; Dastidar SG; Ray A
Expert Opin Investig Drugs; 2014 Jul; 23(7):893-910. PubMed ID: 24766571
[TBL] [Abstract][Full Text] [Related]
6. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.
Knipe RS; Tager AM; Liao JK
Pharmacol Rev; 2015; 67(1):103-17. PubMed ID: 25395505
[TBL] [Abstract][Full Text] [Related]
7. MMP expression and abnormal lung permeability are important determinants of outcome in IPF.
McKeown S; Richter AG; O'Kane C; McAuley DF; Thickett DR
Eur Respir J; 2009 Jan; 33(1):77-84. PubMed ID: 18829682
[TBL] [Abstract][Full Text] [Related]
8. Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF).
Confalonieri P; Volpe MC; Jacob J; Maiocchi S; Salton F; Ruaro B; Confalonieri M; Braga L
Cells; 2022 Jun; 11(13):. PubMed ID: 35805179
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-2 expression in patients with an acute exacerbation of idiopathic interstitial pneumonias.
Ando M; Miyazaki E; Abe T; Ehara C; Goto A; Masuda T; Nishio S; Fujisaki H; Yamasue M; Ishii T; Mukai Y; Ito T; Nureki SI; Kumamoto T; Kadota J
Respir Med; 2016 Aug; 117():27-32. PubMed ID: 27492510
[TBL] [Abstract][Full Text] [Related]
10. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
[No Abstract] [Full Text] [Related]
11. Decline in Mast Cell Density During Diffuse Alveolar Damage in Idiopathic Pulmonary Fibrosis.
Salonen J; Kreus M; Lehtonen S; Vähänikkilä H; Purokivi M; Kaarteenaho R
Inflammation; 2022 Apr; 45(2):768-779. PubMed ID: 34686945
[TBL] [Abstract][Full Text] [Related]
12. Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis.
May J; Mitchell JA; Jenkins RG
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37712420
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
Craig VJ; Zhang L; Hagood JS; Owen CA
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis.
Boesch M; Baty F; Brutsche MH; Tamm M; Roux J; Knudsen L; Gazdhar A; Geiser T; Khan P; Hostettler KE
Respir Res; 2020 Jun; 21(1):165. PubMed ID: 32605572
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of alveolar epithelial injury, repair, and fibrosis.
Chambers RC; Mercer PF
Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S16-20. PubMed ID: 25830828
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.
Collins BF; Raghu G
Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31578210
[TBL] [Abstract][Full Text] [Related]
17. 3D In Vitro Models: Novel Insights into Idiopathic Pulmonary Fibrosis Pathophysiology and Drug Screening.
Vazquez-Armendariz AI; Barroso MM; El Agha E; Herold S
Cells; 2022 May; 11(9):. PubMed ID: 35563831
[TBL] [Abstract][Full Text] [Related]
18. Cellular Senescence in Lung Fibrosis.
Hernandez-Gonzalez F; Faner R; Rojas M; Agustí A; Serrano M; Sellarés J
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209809
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis: evolving concepts.
Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
[TBL] [Abstract][Full Text] [Related]
20. Biopsy in idiopathic pulmonary fibrosis: back to the future.
Rossi G; Spagnolo P
Expert Rev Respir Med; 2017 Sep; 11(9):679-684. PubMed ID: 28673104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
